diallyl trisulfide has been researched along with Hematologic Malignancies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baltes, AK; Burkholz, T; Cerella, C; Czepukojc, B; Dicato, M; Diederich, M; Jacob, C; Kelkel, M; Montenarh, M; Salm, F; Schneider, C; Viswanathan, UM | 1 |
| Calapai, F; Calapai, G; Miroddi, M | 1 |
2 other study(ies) available for diallyl trisulfide and Hematologic Malignancies
| Article | Year |
|---|---|
Synthetic polysulfane derivatives induce cell cycle arrest and apoptotic cell death in human hematopoietic cancer cells.
Topics: Allyl Compounds; Apoptosis; Blotting, Western; Cell Cycle; Hematologic Neoplasms; Humans; Sulfides; U937 Cells | 2014 |
Potential beneficial effects of garlic in oncohematology.
Topics: Allyl Compounds; Animals; Antineoplastic Agents, Phytogenic; Cell Cycle Proteins; Disulfides; Garlic; Hematologic Neoplasms; Histone Deacetylases; Humans; Sulfides; Sulfoxides | 2011 |